EDGAR Filing Documents for 0001564590-20-000918

Form 8-K - Current report:

SEC Accession No. 0001564590-20-000918

Filing Date

2020-01-13

Accepted

2020-01-13 08:41:13

Documents

Period of Report

2020-01-08

Items

Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	srpt-8k_20200108.htm iXBRL	8-K	42258
2	EX-3.1	srpt-ex31_7.htm	EX-3.1	4333
	Complete submission text file	0001564590-20-000918.txt		183914

Data Files

Seq	Description	Document	Type	Size
3	XBRL TAXONOMY EXTENSION SCHEMA	srpt-20200108.xsd	EX-101.SCH	6012
4	XBRL TAXONOMY EXTENSION LABEL LINKBASE	srpt-20200108_lab.xml	EX-101.LAB	20244
5	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	srpt-20200108_pre.xml	EX-101.PRE	12117
14	EXTRACTED XBRL INSTANCE DOCUMENT	srpt-8k_20200108_htm.xml	XML	3689

Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142

Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000

Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)